Federated Hermes Inc. purchased a new position in shares of Shoulder Innovations, Inc. (NYSE:SI – Free Report) during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 200,000 shares of the company’s stock, valued at approximately $2,510,000.
Wall Street Analyst Weigh In
Several brokerages have commented on SI. Weiss Ratings restated a “sell (e)” rating on shares of Shoulder Innovations in a report on Monday, December 29th. Morgan Stanley raised their price objective on shares of Shoulder Innovations from $18.00 to $23.00 and gave the stock an “overweight” rating in a report on Tuesday, December 2nd. Wall Street Zen raised shares of Shoulder Innovations from a “sell” rating to a “hold” rating in a research note on Saturday, October 11th. Piper Sandler reissued an “overweight” rating and issued a $18.00 price target on shares of Shoulder Innovations in a research note on Wednesday, November 12th. Finally, The Goldman Sachs Group reiterated a “buy” rating on shares of Shoulder Innovations in a report on Friday, January 9th. Five investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat, Shoulder Innovations presently has an average rating of “Moderate Buy” and an average price target of $20.60.
View Our Latest Report on Shoulder Innovations
Insider Activity
Shoulder Innovations Price Performance
Shares of NYSE:SI opened at $13.45 on Wednesday. The company has a market cap of $276.97 million and a PE ratio of -0.11. The business’s 50-day simple moving average is $14.74. The company has a quick ratio of 9.80, a current ratio of 11.09 and a debt-to-equity ratio of 0.10. Shoulder Innovations, Inc. has a one year low of $10.92 and a one year high of $17.94.
Shoulder Innovations (NYSE:SI – Get Free Report) last released its earnings results on Tuesday, November 11th. The company reported ($0.48) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.37) by ($0.11). The company had revenue of $11.76 million during the quarter, compared to analyst estimates of $9.99 million. On average, analysts anticipate that Shoulder Innovations, Inc. will post -0.56 earnings per share for the current fiscal year.
About Shoulder Innovations
Shoulder Innovations (NYSE:SI) is a medical device company focused on the design, development and commercialization of shoulder implant systems and related surgical instruments for orthopedic surgery. The company’s product portfolio includes modular shoulder prostheses, humeral and glenoid components, and instrumentation kits designed to facilitate both primary and revision shoulder arthroplasty procedures. Emphasizing a patient-centric approach, Shoulder Innovations works to offer implant solutions that aim to restore mobility and reduce post-operative complications.
In addition to its core implant offerings, Shoulder Innovations provides comprehensive clinical support and training programs for surgeons and operating room teams.
Featured Stories
- Five stocks we like better than Shoulder Innovations
- [No Brainer Gold Play]: “Show me a better investment.”
- This $15 Stock Could Go Down as the #1 Stock of 2026
- What a Former CIA Agent Knows About the Coming Collapse
- BREAKING: Elon Makes a Quiet Shift That Changes Everything
- Ray Dalio Says Buy Gold. I Say Get Paid Every Month From It
Want to see what other hedge funds are holding SI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shoulder Innovations, Inc. (NYSE:SI – Free Report).
Receive News & Ratings for Shoulder Innovations Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shoulder Innovations and related companies with MarketBeat.com's FREE daily email newsletter.
